Display options
Share it on

J Biol Methods. 2021 Sep 27;8:e155. doi: 10.14440/jbm.2021.360. eCollection 2021.

High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples.

Journal of biological methods

Adrian A Pater, Michael S Bosmeny, Adam A White, Rourke J Sylvain, Seth B Eddington, Mansi Parasrampuria, Katy N Ovington, Paige E Metz, Abadat O Yinusa, Christopher L Barkau, Ramadevi Chilamkurthy, Scott W Benzinger, Madison M Hebert, Keith T Gagnon

Affiliations

  1. Chemistry and Biochemistry, Southern Illinois University, Carbondale, IL 62901, USA.
  2. Biochemistry and Molecular Biology, Southern Illinois University School of Medicine, Carbondale, IL 62901, USA.

PMID: 34631911 PMCID: PMC8493558 DOI: 10.14440/jbm.2021.360

Abstract

In late 2019, a novel coronavirus began spreading in Wuhan, China, causing a potentially lethal respiratory viral infection. By early 2020, the novel coronavirus, called SARS-CoV-2, had spread globally, causing the COVID-19 pandemic. The infection and mutation rates of SARS-CoV-2 make it amenable to tracking introduction, spread and evolution by viral genome sequencing. Efforts to develop effective public health policies, therapeutics, or vaccines to treat or prevent COVID-19 are also expected to benefit from tracking mutations of the SARS-CoV-2 virus. Here we describe a set of comprehensive working protocols, from viral RNA extraction to analysis using established visualization tools, for high throughput sequencing of SARS-CoV-2 viral genomes using a MinION instrument. This set of protocols should serve as a reliable "how-to" reference for generating quality SARS-CoV-2 genome sequences with ARTIC primer sets and long-read nanopore sequencing technology. In addition, many of the preparation, quality control, and analysis steps will be generally applicable to other sequencing platforms.

© 2013-2021 The Journal of Biological Methods, All rights reserved.

Keywords: COVID-19; MinION; SARS-CoV-2; genome; nanopore; sequencing

References

  1. BMC Genomics. 2020 Dec 4;21(1):863 - PubMed
  2. J Clin Microbiol. 2016 Oct;54(10):2470-84 - PubMed
  3. Viruses. 2020 Jun 08;12(6): - PubMed
  4. Health Aff (Millwood). 2021 Feb;40(2):204-211 - PubMed
  5. Nat Rev Microbiol. 2017 Mar;15(3):183-192 - PubMed
  6. PLoS One. 2017 Jan 6;12(1):e0169774 - PubMed
  7. Bioinformatics. 2018 Dec 1;34(23):4121-4123 - PubMed
  8. J Clin Virol. 2016 Jun;79:44-50 - PubMed
  9. Antivir Ther. 2012;17(7 Pt B):1465-70 - PubMed
  10. Genome Med. 2021 Feb 9;13(1):21 - PubMed
  11. Cell. 2021 Mar 4;184(5):1127-1132 - PubMed
  12. Nat Protoc. 2017 Jun;12(6):1261-1276 - PubMed
  13. Genome Biol. 2015 Jul 30;16(1):155 - PubMed
  14. Nat Commun. 2020 Dec 9;11(1):6272 - PubMed
  15. PLoS One. 2020 Sep 18;15(9):e0239403 - PubMed
  16. Nat Microbiol. 2020 Nov;5(11):1403-1407 - PubMed
  17. Sci Rep. 2020 Oct 15;10(1):17492 - PubMed

Publication Types